Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Behnam Badie

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Cancer Discovery|April 10, 2021
IFNγ Is Critical for CAR T Cell-Mediated Myeloid Activation and Induction of Endogenous ImmunityDarya Alizadeh, Robyn A Wong, Sharareh Gholamin, et al.
Nature Cancer|February 5, 2022
Targeting PUS7 suppresses tRNA pseudouridylation and glioblastoma tumorigenesisQi Cui, Kailin Yin, Xiaoting Zhang, et al.
Nature Communications|February 4, 2016
Downregulation of TLX induces TET3 expression and inhibits glioblastoma stem cell self-renewal and tumorigenesisQi Cui, Su Yang, Peng Ye, et al.
Cell Reports. Medicine|August 16, 2025
Chlorotoxin-directed CAR T cell therapy for recurrent glioblastoma: Interim clinical experience demonstrating feasibility and safetyMichael E Barish, Maryam Aftabizadeh, Jonathan Hibbard, et al.
Cancer Discovery|December 17, 2020
CRISPR Screening of CAR T Cells and Cancer Stem Cells Reveals Critical Dependencies for Cell-Based TherapiesDongrui Wang, Briana C Prager, Ryan C Gimple, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Pharmacokinetic analysis of carboplatin and fluorescein brain permanence following ultrasound-based blood-brain barrier openingKarl J Habashy, Timothy W Synold, Ye Feng, et al.
Science Translational Medicine|May 10, 2013
Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studiesKaren S Aboody, Joseph Najbauer, Marianne Z Metz, et al.
Neuro-Oncology|February 5, 2016
Phase II multicenter study of gene-mediated cytotoxic immunotherapy as adjuvant to surgical resection for newly diagnosed malignant gliomaLee A Wheeler, Andrea G Manzanera, Susan D Bell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2025
Pharmacokinetic analysis of carboplatin and fluorescein brain retention following ultrasound-based blood-brain barrier openingKarl J Habashy, Timothy W Synold, Ye Feng, et al.
Biorxiv : the Preprint Server for Biology|April 16, 2025
Overcoming myeloid-driven resistance to CAR T therapy by targeting SPP1Sharareh Gholamin, Heini M Natri, Yuqi Zhao, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Cancer Discovery|April 10, 2021
IFNγ Is Critical for CAR T Cell-Mediated Myeloid Activation and Induction of Endogenous ImmunityDarya Alizadeh, Robyn A Wong, Sharareh Gholamin, et al.
Nature Cancer|February 5, 2022
Targeting PUS7 suppresses tRNA pseudouridylation and glioblastoma tumorigenesisQi Cui, Kailin Yin, Xiaoting Zhang, et al.
Nature Communications|February 4, 2016
Downregulation of TLX induces TET3 expression and inhibits glioblastoma stem cell self-renewal and tumorigenesisQi Cui, Su Yang, Peng Ye, et al.
Cell Reports. Medicine|August 16, 2025
Chlorotoxin-directed CAR T cell therapy for recurrent glioblastoma: Interim clinical experience demonstrating feasibility and safetyMichael E Barish, Maryam Aftabizadeh, Jonathan Hibbard, et al.
Cancer Discovery|December 17, 2020
CRISPR Screening of CAR T Cells and Cancer Stem Cells Reveals Critical Dependencies for Cell-Based TherapiesDongrui Wang, Briana C Prager, Ryan C Gimple, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Pharmacokinetic analysis of carboplatin and fluorescein brain permanence following ultrasound-based blood-brain barrier openingKarl J Habashy, Timothy W Synold, Ye Feng, et al.
Science Translational Medicine|May 10, 2013
Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studiesKaren S Aboody, Joseph Najbauer, Marianne Z Metz, et al.
Neuro-Oncology|February 5, 2016
Phase II multicenter study of gene-mediated cytotoxic immunotherapy as adjuvant to surgical resection for newly diagnosed malignant gliomaLee A Wheeler, Andrea G Manzanera, Susan D Bell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2025
Pharmacokinetic analysis of carboplatin and fluorescein brain retention following ultrasound-based blood-brain barrier openingKarl J Habashy, Timothy W Synold, Ye Feng, et al.
Biorxiv : the Preprint Server for Biology|April 16, 2025
Overcoming myeloid-driven resistance to CAR T therapy by targeting SPP1Sharareh Gholamin, Heini M Natri, Yuqi Zhao, et al.
Pageof 10